Denosumab: A cost-effective alternative for older men with osteoporosis from a Swedish payer perspective

A. Parthan, M. Kruse, I. Agodoa, S. Silverman, E. Orwoll

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Denosumab: A cost-effective alternative for older men with osteoporosis from a Swedish payer perspective'. Together they form a unique fingerprint.

Medicine & Life Sciences